Oryon Cell Therapies ("Oryon"), a clinical-stage biotechnology company focused on developing autologous neuron replacement medicines for Parkinson's disease and other neurodegenerative disorders, ...

Oryon Cell Therapies (“Oryon”), a clinical-stage biotechnology company focused on developing autologous neuron replacement ...

Routine early measurement of neurofilament light chain could help improve prediction of cognitive impairment after ...

During intensive care after preterm births, babies can experience low oxygen in their tissue and cells—or hypoxia. Hypoxia is ...

A study has found a new biomarker of schizophrenia, which could also serve as a drug target for treating cognitive symptoms ...

During intensive care after preterm births, babies can experience low oxygen in their tissue and cells—or hypoxia. Hypoxia is linked to poor brain ...

When Ron Cohen, M.D., CEO of Oryon Cell Therapies, recently dug into the company’s Parkinson’s disease data, he told Fierce ...

Oryon Cell Therapies’ lead cell therapy is an autologous treatment designed to replace dopaminergic neurons in patients with ...

Scientists have uncovered a hidden “death switch” in the brain that may be driving Alzheimer’s disease—and even found a way ...

A team led by neurobiologist Prof. Dr. Hilmar Bading at Heidelberg University has identified a key molecular process that drives the progression of ...

Scotland is now screening every newborn for a condition that can kill within two years. Here is what parents across the UK need to know.